novavax covid news - Search News

Order byBest matchMost fresh

Novavax Soars

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who hav...

· 6d · on MSN

STAT · 10h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

WebMD · 3d

FDA Approves Novavax COVID Vaccine With Restricted Use

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

MIT Technology Review · 17h

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 16h

Opinion: The FDA’s new covid vaccine policy is clear as mud

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 11h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

Medical Marketing & Media1d

FDA to limit COVID boosters, Trump touts ‘Most Favored Nation’ framework

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing plan announced last week by President Donald Trump.

4don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.